Antithrombotic Therapy

(A) Angioscopic system evaluating surface of the atrial septal occluder (ASO): low-molecular-weight dextran is infused from the guiding catheter and the tip of the GuideLiner extension catheter during observation. (B) Neointima covering most of the 22 mm ASO 6 months post implantation. (C) Around the central part of the device, the struts were exposed with marked thrombus formation. Guidewire marked by asterisks (*) in panels B and C.

Endothelialization of an Amplatzer Septal Occluder Device 6 Months Post Implantation: Is This Enough Time? An In Vivo Angioscopic Assessment

01/28/2019

Yasuhiro Tanabe, MD, PhD; Yukio Sato, MD, PhD; Masaki Izumo, MD, PhD; Yuki Ishibashi, MD, PhD; Takumi Higuma, MD, PhD; Tomoo Harada, MD, PhD; Yoshihiro J. Akashi, MD, PhD

Yasuhiro Tanabe, MD, PhD; Yukio Sato...

This report evaluates endothelialization in vivo and demonstrates that 6 months of postimplantation prophylactic therapy may not provide sufficient time for adequate endothelialization.

This report evaluates...

01/28/2019

Journal of Invasive Cardiology